FDA Inspection 760361 — Celgene Corp., D.B.A. Abraxis BioScience LLC
The FDA completed an inspection of Celgene Corp., D.B.A. Abraxis BioScience LLC on Dec 20, 2011 in Melrose Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Melrose Park, IL (United States)